AGMB Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-106-K0001104659-26-093390SEC →
2026-08-066-K0001104659-26-091992SEC →
2026-06-236-K0001104659-26-076819SEC →
2026-05-276-K0001104659-26-066590SEC →
2026-05-15SCHEDULE 13G0001172661-26-002216SEC →
2026-05-15SCHEDULE 13G0001104659-26-062718SEC →
2026-05-06SCHEDULE 13G0001193125-26-207455SEC →
2026-04-246-K0001104659-26-048615SEC →
2026-04-2320-F0001104659-26-047872SEC →
2026-04-16SCHEDULE 13G0001213900-26-044365SEC →
2026-03-1830001104659-26-030843SEC →
2026-03-1830001104659-26-030842SEC →
2026-03-1830001104659-26-030841SEC →
2026-03-1830001104659-26-030840SEC →
2026-03-1830001104659-26-030839SEC →
2026-03-1830001104659-26-030838SEC →
2026-03-1830001104659-26-030837SEC →
2026-03-1830001104659-26-030836SEC →
2026-03-1830001104659-26-030835SEC →
2026-03-1830001104659-26-030834SEC →
2026-03-1830001104659-26-030833SEC →
2026-03-11S-80001104659-26-026472SEC →
2026-03-06SCHEDULE 13G0000315066-26-000646SEC →
2026-03-056-K0001104659-26-024095SEC →
2026-02-17SCHEDULE 13D0001193125-26-052946SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
AgomAb Therapeutics NV American (AGMB) — Filings